Evaluate the Safety and Efficacy of HDM1002 Tablets in Overweight and Obese Adults
Status:
NOT_YET_RECRUITING
Trial end date:
2024-11-30
Target enrollment:
Participant gender:
Summary
It is a multicenter, randomized, double-blind, placebo-controlled phase II clinical trial to evaluate the safety and efficacy of HDM1002 tablets in overweight and obese adults.